Platelets, essential for thrombosis and hemostasis, develop from polyp
loid megakaryocytes which undergo endomitosis. During this cell cycle,
cells experience abrogated mitosis and reenter a phase of DNA synthes
is, thus leading to endomitosis. In the search for regulators of the e
ndomitotic cell cycle, se have identified cyclin D3 as an important re
gulatory factor. Of the D-type cyclins, cyclin D3 is present at high l
evels in megakaryocytes undergoing endomitosis and is markedly upregul
ated following exposure to the proliferation-, maturation-, and ploidy
-promoting factor, Mpl ligand, Transgenic mice in which cyclin D3 is o
verexpressed in the platelet lineage display a striking increase in en
domitosis, similar to changes seen following Mpl ligand administration
to normal mice. Electron microscopy analysis revealed that unlike suc
h treated mice, however, D3 transgenic mice show a poor development of
demarcation membranes, from which platelets are believed to fragment,
and no increase in platelets. Thus, while our model supports a key ro
le for cyclin D3 in the endomitotic cell cycle, it also points to the
unique role of Mpl ligand in priming megakaryocytes towards ards plate
let fragmentation. The role of cyclin D3 in promoting endomitosis ist
other lineages programmed to abrogate mitosis will need further explor
ation.